ES508024A0 - "procedimiento para preparar derivados de dihidropiridina". - Google Patents

"procedimiento para preparar derivados de dihidropiridina".

Info

Publication number
ES508024A0
ES508024A0 ES508024A ES508024A ES508024A0 ES 508024 A0 ES508024 A0 ES 508024A0 ES 508024 A ES508024 A ES 508024A ES 508024 A ES508024 A ES 508024A ES 508024 A0 ES508024 A0 ES 508024A0
Authority
ES
Spain
Prior art keywords
dihydropyridine
procedure
preparing derivatives
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES508024A
Other languages
English (en)
Other versions
ES8307220A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of ES8307220A1 publication Critical patent/ES8307220A1/es
Publication of ES508024A0 publication Critical patent/ES508024A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES508024A 1979-12-20 1981-12-16 "procedimiento para preparar derivados de dihidropiridina". Granted ES508024A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7910521A SE7910521L (sv) 1979-12-20 1979-12-20 Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma

Publications (2)

Publication Number Publication Date
ES8307220A1 ES8307220A1 (es) 1982-11-16
ES508024A0 true ES508024A0 (es) 1982-11-16

Family

ID=20339605

Family Applications (4)

Application Number Title Priority Date Filing Date
ES497927A Expired ES8204720A1 (es) 1979-12-20 1980-12-19 Procedimiento para preparar derivados de dihidropiridina
ES508031A Expired ES8306109A1 (es) 1979-12-20 1981-12-16 Procedimiento para preparar derivados de dihidropiridina.
ES508025A Expired ES8307221A1 (es) 1979-12-20 1981-12-16 "procedimiento para preparar derivados de dihidropiridina".
ES508024A Granted ES508024A0 (es) 1979-12-20 1981-12-16 "procedimiento para preparar derivados de dihidropiridina".

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES497927A Expired ES8204720A1 (es) 1979-12-20 1980-12-19 Procedimiento para preparar derivados de dihidropiridina
ES508031A Expired ES8306109A1 (es) 1979-12-20 1981-12-16 Procedimiento para preparar derivados de dihidropiridina.
ES508025A Expired ES8307221A1 (es) 1979-12-20 1981-12-16 "procedimiento para preparar derivados de dihidropiridina".

Country Status (11)

Country Link
EP (1) EP0031801A3 (es)
JP (1) JPS56127356A (es)
AU (1) AU6542380A (es)
DD (1) DD155519A5 (es)
DK (1) DK539980A (es)
ES (4) ES8204720A1 (es)
FI (1) FI803984L (es)
MY (1) MY8500404A (es)
NO (1) NO803856L (es)
SE (1) SE7910521L (es)
ZA (1) ZA807634B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PT77842B (en) * 1982-12-21 1986-05-05 Pfizer Process for preparing dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8415386D0 (en) * 1984-06-15 1984-07-18 Pfizer Ltd Therapeutic agents
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
ES508025A0 (es) 1982-11-01
EP0031801A3 (en) 1981-09-16
ES8307221A1 (es) 1982-11-01
NO803856L (no) 1981-06-22
MY8500404A (en) 1985-12-31
ZA807634B (en) 1981-11-25
ES508031A0 (es) 1982-10-01
DK539980A (da) 1981-06-21
EP0031801A2 (en) 1981-07-08
DD155519A5 (de) 1982-06-16
ES497927A0 (es) 1982-05-01
ES8204720A1 (es) 1982-05-01
AU6542380A (en) 1981-06-25
ES8307220A1 (es) 1982-11-16
SE7910521L (sv) 1981-06-21
JPS56127356A (en) 1981-10-06
ES8306109A1 (es) 1982-10-01
FI803984L (fi) 1981-06-21

Similar Documents

Publication Publication Date Title
MX7199E (es) Procedimiento para preparar derivados de 3-cetodelta-4,9,19-nor-esteroides
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
ES508024A0 (es) "procedimiento para preparar derivados de dihidropiridina".
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
ES491143A0 (es) Procedimiento para la preparacion de derivados de bencimida-zol
MX161397A (es) Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES493931A0 (es) Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina
ES495819A0 (es) Procedimiento de preparar derivados 1,2,4-oxadiazolin-5-oni-cos
ES530574A0 (es) Procedimiento para preparar derivados de pirazol 1,5-a-piridina
MX156097A (es) Procedimento para preparar esteres de derivados de 3-(3-substituido-amino-2-hidroxipropoxi)-4-substituido-1,2,5-tiadiazol
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
ES494286A0 (es) Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos
MX6219E (es) Procedimiento para preparar derivados de 1,1'-bifenil-2-il-alquilamina
MX5454E (es) Procedimiento para preparar derivados de la 1,2,4-triazin-5-ona
ES498146A0 (es) Un procedimiento para preparar derivados de 2,2-dicloroace- tamida
AR223434A1 (es) Procedimiento para la preparacion de derivados de i-piperidino-ftalazina
ES495820A0 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos
MX5188E (es) Procedimiento para preparar derivados de 1,2,3-tiadiazolin-2-ida
MX6595E (es) Procedimiento para preparar derivados de 16 metoxi-16-metil-prostaglandina e1
ES497435A0 (es) Procedimiento para preparar derivados de 2,5-dialcohilfeni- lurea
ES497570A0 (es) Procedimiento de preparacion de derivados de ciclopropilani-linas